In addition, the elevated SPP1 and HMOX1 expression levels were found to be associated with more advanced histological subtypes of glioma, specifically when comparing GBM to astrocytoma, oligodendroglioma and oligoastrocytoma (p < 0.001, Figure 3C). This evidence concerns the gene SPP1 and central nervous system cancer.